896119-95-2

Upstream product

• 97061-77-3 C₁₄H₂₀N₂ 
• 35666-79-6 2-methyl-2-pyrrolidin-1-ylpropionitrile 
• 591-51-5 phenyllithium 

Downstream Products

• 960524-34-9 (R)-[2-methyl-1-phenyl-2-(1-pyrrolidinyl)propyl]amine R-(-)-α-methoxyphenylacetic acid salt 
• 896119-96-3 (R)-(+)-[2-methyl-1-phenyl-2-(1-pyrrolidinyl)propyl]amine 

Relevant academic research and scientific papers

GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE

Compounds of formula (I) and salts and solvates thereof are provided: wherein R1 and R2 are both methyl, or R1 and R2 form a pyrrolidinyl group. Uses in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, such as psych

PYRROLIDINE DERIVATIVES HAVING ACTIVITY AT THE GLYT1 TRANSPORTER

The succinate and napadisylate salts and solvates of 2-(Methyloxy)-/V-[2-methyl-1-phenyl-2- (1-pyrrolidinyl)propyl]-4,6-bis(trifluoromethyl)benzamide,6-bis(trifluoromethyl)benzamide napadisylate, and uses thereof in the treatment of disorders relating to

GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE

Compounds of formula (I) and salts and solvates thereof are provided: wherein either 1 ) R1, R2, R3 and R4 and all methyl, or 2) R1 and R2 form a pyrrolidinyl group and R3 and R4 are both methyl, or 3) R1 and R2 are both methyl and R3 and R4 together form

2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES

The present invention relates to compounds of formula (I), or to salts or solvates thereof, their use in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof. Formula (I) wherein R1 is a group selected from: Formulas (A), (B), (C)